Share Information
ViroGates A/S was listed on Nasdaq First North Denmark (VIRO) on 26 June 2018.
Below you will find information about the ViroGates share.
Our Products
suPARnostic® is developed to measure the amount of suPAR protein (soluble uPAR) in human blood. It is the only CE-IVD certified product range applied for clinical determination of suPAR in human plasma and serum. The suPARnostic® brand consists of the following 3 products:
